Growth Metrics

Aytu Biopharma (AYTU) Other Working Capital Changes (2016 - 2026)

Aytu Biopharma has reported Other Working Capital Changes over the past 15 years, most recently at $4818.0 for Q4 2025.

  • Quarterly Other Working Capital Changes fell 99.38% to $4818.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4818.0 through Dec 2025, down 99.75% year-over-year, with the annual reading at $5078.0 for FY2025, 63.12% up from the prior year.
  • Other Working Capital Changes was $4818.0 for Q4 2025 at Aytu Biopharma, up from -$484000.0 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $1.8 million in Q2 2023 and troughed at -$2.9 million in Q2 2025.
  • The 5-year median for Other Working Capital Changes is $615.0 (2023), against an average of -$81889.2.
  • Year-over-year, Other Working Capital Changes surged 475000.0% in 2021 and then tumbled 297158.82% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at $9502.0 in 2021, then tumbled by 98.95% to $100.0 in 2022, then soared by 515.0% to $615.0 in 2023, then surged by 126729.27% to $780000.0 in 2024, then tumbled by 99.38% to $4818.0 in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Other Working Capital Changes are $4818.0 (Q4 2025), -$484000.0 (Q3 2025), and -$2.9 million (Q2 2025).